Glickman Mark A 4
4 · NeuroBo Pharmaceuticals, Inc. · Filed Jul 28, 2023
Insider Transaction Report
Form 4
Glickman Mark A
Director
Transactions
- Award
Common Stock
2023-07-27+25,000→ 25,000 total - Award
Common Stock
2023-07-27+12,500→ 37,500 total
Footnotes (3)
- [F1]Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan.
- [F2]50% of the RSUs vested immediately, and the remainder will vest in two equal installments on each subsequent anniversary of the date of grant, subject to continuing service.
- [F3]Vests on the earlier of July 27, 2024 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service.